The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008/03/12 by Lynnette K. Nieman, Beverly M. K. Biller, James W. Findling +6 · 45 citations
Medicine · #Pituitary Gland Disorders and Treatments #Adrenal Hormones and Disorders #Adrenal and Paraganglionic Tumors
paper · pdf · doi:10.1210/jc.2008-0125
Abstract
OBJECTIVE: The objective of the study was to develop clinical practice guidelines for the diagnosis of Cushing's syndrome. PARTICIPANTS: The Task Force included a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, five additional experts, a methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions. The guidelines were reviewed and approved sequentially by The Endocrine Society's CGS and Clinical Affairs Core Committee, members responding to a web posting, and The Endocrine Society Council. At each stage the Task Force incorporated needed changes in response to written comments. CONCLUSIONS: After excluding exogenous glucocorticoid use, we recommend testing for Cushing's syndrome in patients with multiple and progressive features compatible with the syndrome, particularly those with a high discriminatory value, and patients with adrenal incidentaloma. We recommend initial use of one test with high diagnostic accuracy (urine cortisol, late night salivary cortisol, 1 mg overnight or 2 mg 48-h dexamethasone suppression test). We recommend that patients with an abnormal result see an endocrinologist and undergo a second test, either one of the above or, in some cases, a serum midnight cortisol or dexamethasone-CRH test. Patients with concordant abnormal results should undergo testing for the cause of Cushing's syndrome. Patients with concordant normal results should not undergo further evaluation. We recommend additional testing in patients with discordant results, normal responses suspected of cyclic hypercortisolism, or initially normal responses who accumulate additional features over time.
Cited by
- A Novel Tool in the Diagnosis and Follow-Up of (Cyclic) Cushing's Syndrome: Measurement of Long-Term Cortisol in Scalp Hair
- Specificity of Screening Tests for Cushing’s Syndrome in an Overweight and Obese Population
- The Treatment of Cushing's Disease
- Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
- Presentation and management of patients with adrenal masses: a large tertiary centre experience
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
- European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
- Long-term metabolic consequences: persistence of visceral obesity and diabetes mellitus after remission from Cushing’s syndrome
- Mortality in Cushing's syndrome: declining over 2 decades but remaining higher than the general population
- 2020 International Society of Hypertension Global Hypertension Practice Guidelines
- Discordance between adrenal vein sampling and imaging: the role of unilateral cortisol excess
- Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
- The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics
- The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study
- Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations
- Accuracy of several parameters of hypothalamic–pituitary–adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma
- Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
- Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT)
- Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease. [europepmc]
- Hair analysis provides a historical record of cortisol levels in Cushing's syndrome. [europepmc]
- Cushing syndrome in pediatrics. [europepmc]
- Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. [europepmc]
- Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. [europepmc]
- A review of rhythm and responsiveness of cortisol in individuals with autism spectrum disorders. [europepmc]
- The physiologic effects of pain on the endocrine system. [europepmc]
- Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers. [europepmc]
- The Treatment of Cushing's Disease. [europepmc]
- Cushing's syndrome: update on signs, symptoms and biochemical screening. [europepmc]
- The Importance of the Biological Impact of Exposure to the Concept of the Exposome. [europepmc]
- "Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study. [europepmc]
- Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population. [europepmc]
- Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. [europepmc]
- Clinical 7 T MRI: Are we there yet? A review about magnetic resonance imaging at ultra-high field. [europepmc]
- A comprehensive diagnostic approach to detect underlying causes of obesity in adults. [europepmc]
- Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism. [europepmc]
- Dynamics of ACTH and Cortisol Secretion and Implications for Disease. [europepmc]
- Adrenal Incidentaloma. [europepmc]
- Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility. [europepmc]
- Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. [europepmc]
- Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation. [europepmc]
- Approach to the Patient With Adrenal Incidentaloma. [europepmc]
- Consensus on diagnosis and management of Cushing's disease: a guideline update. [europepmc]
- Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. [europepmc]
Related